These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14560962)

  • 21. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
    Fingar DC; Salama S; Tsou C; Harlow E; Blenis J
    Genes Dev; 2002 Jun; 16(12):1472-87. PubMed ID: 12080086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a conserved motif required for mTOR signaling.
    Schalm SS; Blenis J
    Curr Biol; 2002 Apr; 12(8):632-9. PubMed ID: 11967149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase.
    Nobukuni T; Joaquin M; Roccio M; Dann SG; Kim SY; Gulati P; Byfield MP; Backer JM; Natt F; Bos JL; Zwartkruis FJ; Thomas G
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14238-43. PubMed ID: 16176982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling.
    Chen J; Fang Y
    Biochem Pharmacol; 2002 Oct; 64(7):1071-7. PubMed ID: 12234610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span.
    Jia K; Chen D; Riddle DL
    Development; 2004 Aug; 131(16):3897-906. PubMed ID: 15253933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.
    Burnett PE; Barrow RK; Cohen NA; Snyder SH; Sabatini DM
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1432-7. PubMed ID: 9465032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression.
    Dai Q; Xu Z; Ma X; Niu N; Zhou S; Xie F; Jiang L; Wang J; Zou W
    Cell Death Differ; 2017 Nov; 24(11):1886-1899. PubMed ID: 28686577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.
    Wysocki PJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):231-41. PubMed ID: 19379082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis.
    Shah OJ; Hunter T
    Mol Cell Biol; 2006 Sep; 26(17):6425-34. PubMed ID: 16914728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR phosphorylated at S2448 binds to raptor and rictor.
    Rosner M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2010 Jan; 38(1):223-8. PubMed ID: 19145465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism.
    Hornberger TA; Stuppard R; Conley KE; Fedele MJ; Fiorotto ML; Chin ER; Esser KA
    Biochem J; 2004 Jun; 380(Pt 3):795-804. PubMed ID: 15030312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focus Issue: demystifying mTOR signaling.
    Gough NR
    Sci Signal; 2009 Apr; 2(67):eg5. PubMed ID: 19383973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling.
    Sabatini DM; Barrow RK; Blackshaw S; Burnett PE; Lai MM; Field ME; Bahr BA; Kirsch J; Betz H; Snyder SH
    Science; 1999 May; 284(5417):1161-4. PubMed ID: 10325225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.